Cargando…

Modeling the competition between lung metastases and the immune system using agents

BACKGROUND: The Triplex cell vaccine is a cancer cellular vaccine that can prevent almost completely the mammary tumor onset in HER-2/neu transgenic mice. In a translational perspective, the activity of the Triplex vaccine was also investigated against lung metastases showing that the vaccine is an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pennisi, Marzio, Pappalardo, Francesco, Palladini, Ariannna, Nicoletti, Giordano, Nanni, Patrizia, Lollini, Pier-Luigi, Motta, Santo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Proceedings
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957681/ https://www.ncbi.nlm.nih.gov/pubmed/21106120 http://dx.doi.org/10.1186/1471-2105-11-S7-S13

Ejemplares similares

Mathematical modeling of the immune system recognition to mammary carcinoma antigen
por: Bianca, Carlo, et al.
Publicado: (2012)

Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator
por: Lollini, Pier-Luigi, et al.
Publicado: (2006)

Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
por: De Giovanni, Carla, et al.
Publicado: (2019)

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
por: De Giovanni, Carla, et al.
Publicado: (2021)

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
por: De Giovanni, Carla, et al.
Publicado: (2019)

Agent-Based Modeling of the Immune System: NetLogo, a Promising Framework
por: Chiacchio, Ferdinando, et al.
Publicado: (2014)

Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases
por: Leoni, Valerio, et al.
Publicado: (2015)

Cancer immunoprevention: from mice to early clinical trials
por: Palladini, Arianna, et al.
Publicado: (2018)

A methodological approach for using high-level Petri Nets to model the immune system response
por: Pennisi, Marzio, et al.
Publicado: (2016)

A novel paradigm for cell and molecule interaction ontology: from the CMM model to IMGT-ONTOLOGY
por: Pappalardo, Francesco, et al.
Publicado: (2010)

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
por: De Giovanni, Carla, et al.
Publicado: (2019)

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Nanni, Patrizia, et al.
Publicado: (2018)

SimB16: Modeling Induced Immune System Response against B16-Melanoma
por: Pappalardo, Francesco, et al.
Publicado: (2011)

Parallelisation strategies for agent based simulation of immune systems
por: Kabiri Chimeh, Mozhgan, et al.
Publicado: (2019)

A Mathematical Model of Immune-System-Melanoma Competition
por: Pennisi, Marzio
Publicado: (2012)

IFN-γ and CD38 in Hyperprogressive Cancer Development
por: Angelicola, Stefania, et al.
Publicado: (2021)

2011: the immune hallmarks of cancer
por: Cavallo, Federica, et al.
Publicado: (2011)

Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice
por: Ianzano, Marianna L., et al.
Publicado: (2013)

Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
por: Pappalardo, Francesco, et al.
Publicado: (2016)

Modelling vaccination schedules for a cancer immunoprevention vaccine
por: Motta, Santo, et al.
Publicado: (2005)

Preclinical Therapy of Disseminated HER-2(+) Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus
por: Nanni, Patrizia, et al.
Publicado: (2013)

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Croci, Stefania, et al.
Publicado: (2015)

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas
por: Landuzzi, Lorena, et al.
Publicado: (2014)

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
por: Giusti, Veronica, et al.
Publicado: (2021)

In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
por: Russo, Giulia, et al.
Publicado: (2020)

Preclinical HER-2 Vaccines: From Rodent to Human HER-2
por: Lollini, Pier-Luigi, et al.
Publicado: (2013)

Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET
por: Pantaleo, Maria A., et al.
Publicado: (2010)

Multiorgan Metastasis of Human HER-2(+) Breast Cancer in Rag2(−/−);Il2rg(−/−) Mice and Treatment with PI3K Inhibitor
por: Nanni, Patrizia, et al.
Publicado: (2012)

Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis
por: Pennisi, Marzio, et al.
Publicado: (2013)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023)

The Promise of Preventive Cancer Vaccines
por: Lollini, Pier-Luigi, et al.
Publicado: (2015)

Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus
por: Pennisi, Marzio, et al.
Publicado: (2017)

The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis
por: Pappalardo, Francesco, et al.
Publicado: (2020)

Model verification tools: a computational framework for verification assessment of mechanistic agent-based models
por: Russo, Giulia, et al.
Publicado: (2022)

Toward computational modelling on immune system function
por: Pappalardo, Francesco, et al.
Publicado: (2019)

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2
por: De Giovanni, Carla, et al.
Publicado: (2014)

In Silico Modeling of the Immune System: Cellular and Molecular Scale Approaches
por: Belfiore, Mariagrazia, et al.
Publicado: (2014)

Verification of an agent‐based disease model of human Mycobacterium tuberculosis infection
por: Curreli, Cristina, et al.
Publicado: (2021)

Migration of liver sinusoidal leukocytes to the liver colon adenocarcinoma metastases
por: Durowicz, Sergiusz, et al.
Publicado: (2004)

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
por: Lamberti, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0t3nb7i3do3c6gfe7qeifpassc